B-cell-specific signatures reveal novel immunophenotyping and therapeutic targets for hepatocellular carcinoma.

Regarding immune microenvironment analysis, patients with HCC in the high-risk score group showed a trend towards decreased stromal score ( P = 0.063), immune score ( P = 0.056), and estimate score ( P = 0.051), although the lack of significant differences may be attributed to the small sample size (Figure 8A–C ).

also in 53,322 other papers